# AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA

> **NCT01656967** · NA · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 66 (actual)

## Conditions studied

- Supraglottic Airway

## Interventions

- **DEVICE:** AMBU Aura-I/aScope 2
- **DEVICE:** LMA Fastrach Single Use

## Key facts

- **NCT ID:** NCT01656967
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656967, "AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01656967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*